Joseph Whitters - InfuSystems Holdings Independent Director
| INFU Stock | USD 7.78 0.27 3.60% |
Director
Mr. Joseph E. Whitters serves as Independent Director of Infusystem Holdings, Inc., since April 24, 2012. Mr. Whitters was an Advisor to Frazier Health Care, a VC and private equity firm since 2005. From 1986 to January 2005, Mr. Whitters was employed in various capacities with First Health Group Corporationration, a nearly 2 billion market capitalization managed healthcare company serving the group health, workers compensation, and state agency markets, including as Chief Financial Officer and Executive Vice President. Prior to joining First Health in 1986, he served as Controller for United HealthCare Corporationration In January 2013, he joined the board of directors of PRGX Global, Inc., a business service enterprise, where he also serves on the Compensation Committee and Audit Committee. Previously, he served on the boards of directors and the audit committees of various public companies including Omnicell, Mentor Corporation, Solexa, and Luminent Mortgage . Mr. Whitters has also been an advisor or board member with several private companies. Mr. Whitters began his career in public accounting with Peat Marwick and has a Bachelors of Arts in accounting degree from Luther College in Iowa. Mr. Whitters is a certified public accountant. since 2012.
| Age | 60 |
| Tenure | 12 years |
| Address | 3851 West Hamlin Road, Rochester Hills, MI, United States, 48309 |
| Phone | 248-291-1210 |
| Web | https://www.infusystem.com |
Joseph Whitters Latest Insider Activity
Tracking and analyzing the buying and selling activities of Joseph Whitters against InfuSystems Holdings stock is an integral part of due diligence when investing in InfuSystems Holdings. Joseph Whitters insider activity provides valuable insight into whether InfuSystems Holdings is net buyers or sellers over its current business cycle. Note, InfuSystems Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell InfuSystems Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Joseph Whitters over three months ago Acquisition by Joseph Whitters of 56603 shares of Accuray Incorporated subject to Rule 16b-3 | ||
Joseph Whitters over a year ago Purchase by Joseph Whitters of 5000 shares of PRGX Global, | ||
Joseph Whitters over a year ago Acquisition by Joseph Whitters of 13779 shares of PRGX Global, subject to Rule 16b-3 |
InfuSystems Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0253 % which means that it generated a profit of $0.0253 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0174 %, meaning that it created $0.0174 on every $100 dollars invested by stockholders. InfuSystems Holdings' management efficiency ratios could be used to measure how well InfuSystems Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, InfuSystems Holdings' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop 0.04 in 2024. At this time, InfuSystems Holdings' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 3.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 15.5 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Wilfred OGara | LSI Industries | 60 | |
| Scott Gottlieb | Pfizer Inc | 48 | |
| Shantanu Narayen | Pfizer Inc | 57 | |
| Helen Hobbs | Pfizer Inc | 68 | |
| Dan Littman | Pfizer Inc | 68 | |
| Ronald Blaylock | Pfizer Inc | 61 | |
| Kathy Warden | Merck Company | 49 | |
| Rochelle Lazarus | Merck Company | 71 | |
| Amy Hanson | LSI Industries | N/A | |
| Robert Steele | LSI Industries | 62 | |
| Frances Fergusson | Pfizer Inc | 71 | |
| Stephanie Burns | HP Inc | 66 | |
| Aida Alvarez | HP Inc | 71 | |
| Robert Bennett | HP Inc | 62 | |
| Pamela Craig | Merck Company | 64 | |
| James Skinner | HP Inc | 70 | |
| Susan Hockfield | Pfizer Inc | 70 | |
| Don Cornwell | Pfizer Inc | 69 | |
| Stacey Mobley | HP Inc | 73 | |
| John Noseworthy | Merck Company | 66 | |
| Yoky Matsuoka | HP Inc | 46 | |
Management Performance
| Return On Equity | 0.0174 | ||||
| Return On Asset | 0.0253 |
InfuSystems Holdings Leadership Team
Elected by the shareholders, the InfuSystems Holdings' board of directors comprises two types of representatives: InfuSystems Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InfuSystems. The board's role is to monitor InfuSystems Holdings' management team and ensure that shareholders' interests are well served. InfuSystems Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InfuSystems Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Ruiz, Ex Officer | ||
| Greg Schulte, CFO | ||
| Darrell Montgomery, Director | ||
| Richard Diiorio, President CEO, Director | ||
| Barry Steele, Executive CFO | ||
| Scott Shuda, Director | ||
| Joseph Whitters, Independent Director | ||
| BSN MBA, COO Pres | ||
| Christopher Sansone, Director | ||
| Jonathan Foster, CFO | ||
| David Dreyer, Independent Director | ||
| Wayne Yetter, Independent Director | ||
| Addam Chupa, Executive Officer | ||
| Ryan Morris, Non-Executive Chairman of the Board | ||
| Michael McReynolds, CIO and Executive VP | ||
| Trent Smith, Executive Vice President Chief Accounting Officer, Corporate Controller | ||
| Gregory Schulte, CFO | ||
| Jeanie Latz, Corporate Secretary | ||
| Christopher Downs, Interim CFO, Executive Vice President | ||
| Jerod Funke, Executive Officer | ||
| Janet Skonieczny, COO and Executive VP | ||
| Rob Swadosh, IR Contact | ||
| Eric Steen, CEO and President and Director | ||
| Jeannine Sheehan, Exec Officer | ||
| Gregg Lehman, Director |
InfuSystems Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InfuSystems Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0174 | ||||
| Return On Asset | 0.0253 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 195.84 M | ||||
| Shares Outstanding | 21.26 M | ||||
| Shares Owned By Insiders | 5.81 % | ||||
| Shares Owned By Institutions | 82.19 % | ||||
| Number Of Shares Shorted | 215.36 K | ||||
| Price To Earning | 10.72 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InfuSystems Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InfuSystems Holdings' short interest history, or implied volatility extrapolated from InfuSystems Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InfuSystems Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy InfuSystems Stock please use our How to Invest in InfuSystems Holdings guide.Note that the InfuSystems Holdings information on this page should be used as a complementary analysis to other InfuSystems Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for InfuSystems Stock analysis
When running InfuSystems Holdings' price analysis, check to measure InfuSystems Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InfuSystems Holdings is operating at the current time. Most of InfuSystems Holdings' value examination focuses on studying past and present price action to predict the probability of InfuSystems Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InfuSystems Holdings' price. Additionally, you may evaluate how the addition of InfuSystems Holdings to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is InfuSystems Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InfuSystems Holdings. If investors know InfuSystems will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InfuSystems Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.04 | Revenue Per Share 5.983 | Quarterly Revenue Growth 0.101 | Return On Assets 0.0253 |
The market value of InfuSystems Holdings is measured differently than its book value, which is the value of InfuSystems that is recorded on the company's balance sheet. Investors also form their own opinion of InfuSystems Holdings' value that differs from its market value or its book value, called intrinsic value, which is InfuSystems Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InfuSystems Holdings' market value can be influenced by many factors that don't directly affect InfuSystems Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InfuSystems Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if InfuSystems Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InfuSystems Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.